The Journal invites authors to submit original research, reviews or commentaries on a variety of Travel Medicine related topics. Papers
submitted must not have been previously published or being considered for publication elsewhere. Submission of a manuscript to this journal
gives the publisher the right to publish that paper if it is accepted. Manuscripts may be edited to improve clarity and expression.
Jane Zuckerman c/o Academic Centre for Travel Medicine and Vaccines WHO Collaborating Centre
for Reference, Research and Training in Travel Medicine Royal Free and University College Medical School Royal Free Campus Rowland
Hill Street London NW3 2PF United Kingdom
One complete electronic copy of the manuscript should be submitted, together with one set of files of the figures; authors should
retain a backup copy of the manuscript.
Original articles should be between 6,000 and 8,000 words in length; review articles should
be 8,000 - 10,000 words in length, commentaries should be 2,000 words in length and correspondence should be up to 500 words in length.
Conflict of Interest Travel Medicine and Infectious Disease will not publish manuscripts unless submitted manuscripts
contain a Conflict of Interest Declaration. Authors should include a statement disclosing any financial or personal relationship with
other people or organisations that could inappropriately influence their work. Manuscripts which are submitted without this declaration
will be sent back with a request for this to be included.
Authorship All authors should have made substantial contributions
to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data,
(2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Manuscript Preparation Papers should be submitted in journal style and must be written in good English. Failure to do
so may lead to significant delays in publication. Spelling may be British or American, but this must be consistent throughout the paper.
It is highly recommended that authors use the "spell-checking" facility on their word processing software.
Avoid full justification,
i.e., do not use a constant right-hand margin. Ensure that each new paragraph is clearly indicated. Present tables and figure legends
on separate pages at the end of the manuscript. If possible, consult a recent issue of the journal to become familiar with layout and
conventions. Number all pages consecutively.
Authors should note that upon submission of their manuscripts to the Editor, they must
ensure that they have adhered to the following checklist: - One author is designated as the corresponding author and provides the
following information: E-mail address, Full postal address, Telephone and fax numbers, - All text pages - Keywords (3 - 6 words)
- Original artwork (high-quality jpgs or tiffs) - All figure captions - All tables (including title, description, footnotes)
A covering letter signed by all authors should accompany the manuscript, identifying the person (with the full address, telephone
and fax numbers and email address) responsible for negotiations concerning the manuscript; the letter should make it clear that the final
manuscript has been seen and approved by all authors.
During the submission process, authors will be asked to submit the names and
contact details of up to four potential referees.
Papers should be set out as follows, with each section beginning on a separate
sheet: Title Page, Abstract, Key words (3-6), Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References,
Tables and Figures with legends. The Editor will consider the use of other sections if more suitable for certain manuscripts.
Title
page: The title page should give the following information (in the order stated): - Title. Concise and informative,
the title should be informative and not exceed 85 characters, including spaces. Titles are often used in information-retrieval systems.
Avoid abbreviations and formulae where possible. Avoid use of extraneous words such as "study", "investigation", etc. - Author
names, qualifications and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly.
State the authors' highest-earned degree. Present the authors' affiliation addresses (where the actual work was done) below the names.
Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address.
Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.
- Corresponding author. Clearly indicate who is willing to handle correspondence at all stages of refereeing and publication,
also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address
and the complete postal address. - Present/permanent address. If an author has moved since the work described in the
article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's
name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals
are used for such footnotes. - Other information. If data from the manuscript have been presented at a meeting, list the
full name, date and location of the meeting and reference any previous published abstracts in the bibliography.
Authorship should
be assumed only by those who have contributed materially to the work and its report. Colleagues who have otherwise assisted or collaborated
should be recognised in the Acknowledgement section.
Abstract: Original articles should include a structured abstract of
no more than 200 words. In original articles, the Abstract should consist of 4 paragraphs, labelled Background, Method, Results, Conclusions.
They should briefly describe the problems being addressed in the study, how the study was performed and which measurements were carried
out, the most relevant results, and what the authors conclude from the results. A recent copy of the journal should be consulted as
a guide. An abstract is often presented separate from the article, so it must be able to stand alone.
Keywords: Authors
should provide a list of 3 - 6 keywords (not used in the title) on the first page of the manuscript, avoiding general and plural terms
and multiple concepts (avoid, for example, 'and', 'of'). Use terms form the Medical Subject headings from the Index Medicus. Be sparing
with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes.
DNA sequences and GenBank Accession numbers: Many Elsevier journals cite "gene accession numbers" in their running text
and footnotes. Gene accession numbers refer to genes or DNA sequences about which further information can be found in the databases at
the National Center for Biotechnical Information (NCBI) at the National Library of Medicine. Elsevier authors wishing to enable other
scientists to use the accession numbers cited in their papers via links to these sources, should type this information in the following
manner:
For each and every accession number cited in an article, authors should type the accession number in bold,
underlined text. Letters in the accession number should always be capitalised. (See Example below). This combination of letters
and format will enable Elsevier's typesetters to recognise the relevant texts as accession numbers and add the required link to GenBank's
sequences.
Example: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228),
a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession
no. AA361117)".
Authors are encouraged to check accession numbers used very carefully. An error in a letter or
number can result in a dead link. In the final version of the electronic copy, the accession number text will be linked
to the appropriate source in the NCBI databases enabling readers to go directly to that source from the article.
Introduction:
The Introduction should be brief and set out the purposes for which the study has been performed.
Materials and Methods:
The Materials and Methods should be sufficiently detailed so that readers and reviewers can understand precisely what has been done without
studying the references directly. The description may be abbreviated when well accepted techniques are used.
Results: The
Results should be presented precisely. Keep discussion of their importance to a minimum in this section of the manuscript.
Discussion: The Discussion should directly relate to the study being reported. Do not include a general review of the topic.
Do not use
"he", "his", etc where the sex of the person is unknown; say "the patient", etc. Avoid inelegant alternatives such as "he/she". Patients
should not be automatically designated as "she", and doctors as "he".
ILLUSTRATIONS The electronic text should be prepared
as done for conventional manuscripts (see also the Author's Guide to Publishing with Elsevier: www.elsevier.com/authors).
Do not import the figures into the text file but, instead, indicate their approximate locations directly in the electronic text and on
the manuscript. See also the section on the Preparation of electronic illustrations. Colour figures must be clearly marked as
being intended for colour reproduction or to be reproduced in black-and-white. Reproduction of colour figures will incur a charge to
the author; however if both colour and black-and-white figures (of the same figure) are supplied, it is possible to have the black-and-white
image appear in print, and the colour image to appear on the online version at no extra cost. Please indicate if you would prefer this
at the time of submission.
Patient confidentiality: Where illustrations must include recognizable individuals, living or
dead or of whatever age, great care must be taken to ensure that consent for publication has been given. If identifiable features are
not essential to the illustration, please indicate where the illustration can be cropped. In cases where consent has not been obtained
and recognisable features may appear, it will be necessary to retouch the illustration to mask the eyes or otherwise render the individual
"officially unrecognisable".
Permissions to reproduce borrowed illustrations or tables or identifiable clinical photographs: Written permission to reproduce borrowed material (illustrations and tables) must be obtained from the original publishers and authors,
and submitted with the typescript. Borrowed material should be acknowledged in the captions in this style: 'Reproduced by the kind permission
of . . . (publishers) from . . . (reference)'.
TABLES When preparing tables, if you are using a table grid, use only one
grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns.
Tables should
be typed with double spacing each on a separate sheet, numbered consecutively in accordance with their appearance in the text. A short
descriptive title should appear above each table and footnotes to tables are to be placed below the table body and indicate them with
superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do
not duplicate results described elsewhere in the article.
REFERENCES References should be numbered consecutively (in square
brackets) as they appear in the text. Type the reference list with double spacing on a separate sheet.
Text: Indicate references
by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always
be given.
List: Number the references (numbers in square brackets) in the list in the order in which they appear in the
text.
Examples:
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing
a scientific article. J Sci Commun 2000;163:51-9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements of style. 3rd
ed. New York: Macmillan; 1979.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare an electronic
version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 1999, p. 281-304
Note shortened form for last page number. e.g., 51-9, and that for more than 6 authors the first 6 should be listed followed by 'et
al.' For further details you are referred to "Uniform Requirements for Manuscripts submitted to Biomedical Journals" (J Am Med Assoc
1997;277:927-934) (see also http://www.nejm.org/general/text/requirements/1.htm)
Please note that all authors should be
listed when six or less; when seven or more, list only the first three and add et al. Do not list references to personal communications,
unpublished data or manuscripts either in preparation or submitted for publication. If essential, such material may be incorporated into
the appropriate place in the text. Recheck references in the text against reference list after your manuscript has been revised.
Digital
Object Identifier Elsevier assigns a unique digital object identifier (DOI) to every article it publishes. The DOI appears on
the title page of the article. It is assigned after the article has been accepted for publication and persists throughout the lifetime
of the article. Due to its persistence, it can be used to query Elsevier for information on the article during the production process,
to find the article on the Internet through various Web sites, including ScienceDirect, and to cite the article in academic references.
When using an Elsevier article in a reference section, it is important to include the article's DOI in the reference as volume and page
information is not always available for articles published online. The References section shows samples of DOI included in references.
Brief reports Brief reports containing concise reports on original work will be considered for publication. Case Reports which
are relevant for understanding the pathophysiology or clinical presentation of Infectious Disease may also be accepted under this heading.
Articles published in this section should preferably be no more than 2,000 words, 3-6 key words, preferably be no more than 2 figures
and /or tables, and references.
Correspondence Correspondence may be submitted to the journal in the form of Letters to
the Editor or short papers of no more than 500 words. Tables, figures and references should be kept to a minimum.
Book Reviews Submission of book reviews of up to 450 words may be submitted to the Editor along the same route as normal manuscripts. Books for
reviews may also be sent to the Editor at the address given above.
Abbreviations Measurements should be abbreviated according
to SI units. All other abbreviations or acronyms should be defined on first appearance in the text. Use a capital letter for proprietary
names of substances and materials. At first mention of a chemical substance, use the correct chemical designation as well as the generic
name.
Policy and Ethics Work on human beings that is submitted to Travel Medicine and Infectious Diseases should
comply with the principles laid down in the Declaration of Helsinki; Recommendations guiding physicians in biomedical research involving
human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly,
Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong,
September 1989. The manuscript should contain a statement that the work has been approved by the appropriate ethical committees related
to the institution(s) in which it was performed and that subjects gave informed consent to the work. Studies involving experiments with
animals must state that their care was in accordance with institution guidelines. Patients' and volunteers' names, initials, and hospital
numbers should not be used.
Acknowledgements All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section.
Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department
chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that
paid for this assistance.
Role of the funding source
All sources of funding should be declared as an acknowledgement at the
end of the text. Authors should declare the role of study sponsors, if any, in the study design, in the collection, analysis and interpretation
of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no
such involvement, the authors should so state.
Proofs Proofs will be sent to the authors to be carefully checked for
printer's errors. Changes or additions to the edited manuscript cannot be allowed at this stage. Corrected proofs should be returned
to the publisher within 2 days of receipt.
Reprints
Travel Medicine and Infectious Disease has no page
charges. Twenty-five free reprints will be supplied per article. The publisher will send authors a form enabling further reprints to
be ordered at prices listed on it.
Copyright Information All authors must sign the "Transfer of Copyright" agreement before
the article can be published. This agreement enables Elsevier Ltd to protect the copyrighted materials for the authors, but does not
relinquish the author's proprietary rights. The copyright transfer covers the exclusive rights to reproduce and distribute the paper,
including reprints, photographic reproductions, microfilm or any other reproductions of similar nature and translations. It includes
the right to adapt the article for use in conjunction with computer systems and programmes, including reproduction or publication in
machine-readable form and incorporation in retrieval systems. Authors are responsible for obtaining from the copyright holder permission
to reproduce any figures for which copyright exists.
Upon acceptance of an article, authors will be asked to sign a ?Journal Publishing
Agreement?? (for more information on this and copyright see http://www.elsevier.com/wps/find/authorsview.authors/copyright ). Acceptance of the agreement will ensure
the widest possible dissemination of information. An e-mail (or letter) will be sent to the corresponding author confirming receipt of
the manuscript together with a `Journal Publishing Agreement? form.
If excerpts from other copyrighted works are included, the author(s)
must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use
by authors in these cases : contact Elsevier's Rights Department, Philadelphia, PA, USA: Tel. (+1) 215 238 7869; Fax (+1) 215 238 2239;
e-mail healthpermissions@elsevier.com . Requests may also be completed online via the Elsevier homepage (
http://www.elsevier.com/locate/permissions ).
Funding body agreements and policies Elsevier has established
and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript
archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please
visit http://www.elsevier.com/fundingbodies
